Your potential investigator / KOL is very enthusiastic to do your study but does not have an experienced research team, or no study team at all. But he is the only one who has sufficient product usage to conduct a retrospective PMCF study. What do you do?
If you have experience with conducting clinical trials at a device manufacturer, odds are that you have had your close encounter with the research naïve study site. The research naïve study site features an enthusiastic clinician, who promises he or she has plenty of time after hours to enter study data into your “system”. Maybe they even have a secretary or student at their disposal who can “take care of the paperwork”. Reasons to go for research naïve sites can be many. Including the need for specific patient populations or real-world patient populations, geographical spread, product usage (in case of retrospective studies for example), the medical field you are operating in. If you find yourself with no other option than to contract the research naïve site, how do you prevent failure? And is there even the possibility of success?
Even for the most seasoned research sites, any clinical trial is a challenge. Trials involve a huge administrative burden, different procedures, data capture systems, and sponsor peculiarities, establishing communication channels, building relationships, and freeing up time from personnel in an already busy environment. A site needs time, man-hours and experience to take on such a task.
Naïve sites underestimate the time commitment and lack of dedicated research personnel. If your investigator decides to assign study-related tasks to his or her regular daily staff, such as nurses, resident students or even secretaries without understanding the workload this represents, you will soon be faced with underperformance. The site’s lack of experience is likely to lead to non-conformities which will take a lot of resources to address. When this happens, initial enthusiasm at the site can quickly turn to disappointment.
If not managed properly, you risk entering a downward spiral of dropping enrolment rates, non-conformity pile-up and communication issues. Sometimes the situation can be repaired, other times the site needs to be abandoned. On the Sponsor’s end, the trial budget and timelines suffer the consequences and the relationship with the investigator – often also a customer – gets damaged.
First of all its probably best not to use those sites for critical or high-risk trials, but a less complex, low-risk study such as a retrospective data collection or observational post-market clinical follow-up study may have a chance of success when the following is taken into account:
Even when you are working with a dedicated academic research team that runs complex premarket studies around the clock, managing a clinical trial is always a challenge. Research naïve poses additional challenges due to lack of experience and often resources. But everyone starts somewhere, and research sites are no exception. If you are willing to spend the additional resources to prepare, train and guide the site you may be investing not only in a good outcome of the study but also in a rewarding, long-lasting relationship with the site. You give them a chance to prove themselves and they may turn out a very grateful advocate to have on your side.
We are a medical device dedicated CRO and we have experience with research naïve sites. Next, to our standard CRO services, we can provide customized site training and can help with site selection. We pride ourselves in our pragmatic approach. Contact us for more information.